These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3981310)

  • 1. Impaired granulocyte chemotaxis and increased circulating immune complexes in Kawasaki disease.
    Ono S; Onimaru T; Kawakami K; Hokonohara M; Miyata K
    J Pediatr; 1985 Apr; 106(4):567-70. PubMed ID: 3981310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating immune complexes and granulocytes chemotaxis in Kawasaki disease.
    Miyata K; Kawakami K; Onimaru T; Baba Y; Ono S; Hokonohara M; Yoshinaga M; Terawaki T
    Jpn Circ J; 1984 Dec; 48(12):1350-3. PubMed ID: 6512943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating immune complexes in Kawasaki syndrome.
    Mason WH; Jordan SC; Sakai R; Takahashi M; Bernstein B
    Pediatr Infect Dis; 1985; 4(1):48-51. PubMed ID: 3881741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of circulating immune complexes with granulocyte function in patients with rheumatoid arthritis.
    Bültmann B; Geitner R; Seibold H; Kratsch G; Haferkamp O
    Klin Wochenschr; 1980 Jul; 58(14):727-32. PubMed ID: 7453086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High levels of IgA-containing circulating immune complex and secretory IgA in Kawasaki disease.
    Ohshio G; Furukawa F; Khine M; Yoshioka H; Kudo H; Hamashima Y
    Microbiol Immunol; 1987; 31(9):891-8. PubMed ID: 3696008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet immune complex interaction in pathogenesis of Kawasaki disease and childhood polyarteritis.
    Levin M; Holland PC; Nokes TJ; Novelli V; Mola M; Levinsky RJ; Dillon MJ; Barratt TM; Marshall WC
    Br Med J (Clin Res Ed); 1985 May; 290(6480):1456-60. PubMed ID: 3922532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased circulating granulocyte colony-stimulating factor in acute Kawasaki disease.
    Inoue Y; Kato M; Kobayashi T; Shinohara M; Sone K; Morikawa A
    Pediatr Int; 1999 Jun; 41(3):330-3. PubMed ID: 10365591
    [No Abstract]   [Full Text] [Related]  

  • 8. Circulating immune complexes in mucocutaneous lymph-node syndrome (Kawasaki disease).
    Weindling AM; Levinsky RJ; Marshall WC; Hood J
    Arch Dis Child; 1979 Mar; 54(3):241-2. PubMed ID: 434916
    [No Abstract]   [Full Text] [Related]  

  • 9. [IgG subclasses in the serum and circulating immune complexes in patients with Kawasaki disease].
    Li CR
    Zhonghua Yi Xue Za Zhi; 1989 Oct; 69(10):578-81, 40. PubMed ID: 2620267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kawasaki Disease: The Role of Immune Complexes Revisited.
    Menikou S; Langford PR; Levin M
    Front Immunol; 2019; 10():1156. PubMed ID: 31263461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kawasaki disease: monitoring of circulating immune complexes.
    Salo E; Kekomäki R; Pelkonen P; Ruuskanen O; Viander M; Wagner O
    Eur J Pediatr; 1988 May; 147(4):377-80. PubMed ID: 3294012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current viewpoints in the pathogenesis of Kawasaki disease].
    Bollen CW; Rijkers GT; Zegers BJ; de Graeff-Meeder ER
    Ned Tijdschr Geneeskd; 1995 Mar; 139(11):549-54. PubMed ID: 7700390
    [No Abstract]   [Full Text] [Related]  

  • 13. Kawasaki disease: circulating immune complexes monitored during the disease.
    Salo E; Pelkonen P; Kekomaki R; Ruuskanen O; Viander M; Wager O
    Prog Clin Biol Res; 1987; 250():563. PubMed ID: 3423075
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study on peripheral blood mononuclear cell subpopulations in patients with Kawasaki disease by fluorescence activated cell sorter using two-colour immunofluorescence staining].
    Jujho K
    Arerugi; 1985 Dec; 34(12):1072-80. PubMed ID: 2420314
    [No Abstract]   [Full Text] [Related]  

  • 15. [A study of immune complexes in Kawasaki disease].
    Yanase Y; Kawasaki T; Yoshinoya S; Aikawa T; Hashimoto Y; Mitamura T; Miyoshi Y; Muranaka M; Miyamoto T
    Arerugi; 1984 Jan; 33(1):59-65. PubMed ID: 6743029
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune complexes in Kawasaki syndrome: a review.
    Pachman LM; Herold BC; Davis AT; Hang LM; Schaller JG; Beckwith B; Arroyave CM; Gawryl MS; Lint T; Shulman ST
    Prog Clin Biol Res; 1987; 250():193-207. PubMed ID: 3321076
    [No Abstract]   [Full Text] [Related]  

  • 17. Kawasaki disease.
    Samuel J; O'Sullivan J
    Br J Hosp Med; 1996 Jan 17-Feb 6; 55(1-2):9-14. PubMed ID: 8646401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Function of phagocytosis and intracellular killing of peripheral neutrophils in Kawasaki disease.
    Tasaka K; Hamashima Y
    Acta Pathol Jpn; 1978 Mar; 28(2):247-52. PubMed ID: 676746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating soluble L-selectin levels in Kawasaki disease with coronary artery lesions.
    Hirao J; Yamashita T
    Acta Paediatr Jpn; 1997 Apr; 39(2):290-2. PubMed ID: 9141275
    [No Abstract]   [Full Text] [Related]  

  • 20. Circulating soluble CD23 levels in Kawasaki disease with coronary artery lesions.
    Hirao J; Yamashita T
    Acta Paediatr Jpn; 1997 Jun; 39(3):397-9. PubMed ID: 9241913
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.